{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:02:34Z","timestamp":1790730154040,"version":"4.1.0"},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>This pilot study aimed to confirm the presence of infectious agents in infection foci using PET\/CT imaging with <jats:sup>68<\/jats:sup>Ga-DOTA-UBI<jats:sub> (29\u201341)<\/jats:sub> in 7 patients with chronic osteomyelitis and with indications for surgical cleaning at the site of the infection focus. The whole-body PET\/CT was performed on Biograph mCT 40 PET\/CT scanner (Siemens Healthineers); the image began 45\u201360 minutes postinjection of the radiotracer (148\u2013260 MBq). This study demonstrated that, in 6 patients in whom the PET\/CT was classified as positive for identified infectious foci, confirmed by culture of the secretion sample collected during surgery, only 1 patient in antibiotic therapy was negative.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004866","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T18:35:47Z","timestamp":1695839747000},"page":"982-984","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Could 68Ga-DOTA-UBI-29-41 Help Identify Chronic Osteomyelitis on PET\/CT Images? A Pilot Study"],"prefix":"10.1097","volume":"48","author":[{"given":"Solange Amorim","family":"Nogueira","sequence":"first","affiliation":[{"name":"Hospital Israelita Albert Einstein"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marycel F.","family":"de Barboza","sequence":"additional","affiliation":[{"name":"Radiopharmaceutical, Hospital Israelita Albert Einstein"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana M.","family":"Dell\u2019Aquila","sequence":"additional","affiliation":[{"name":"Department of Orthopedics and Traumatology\u2013Escola Paulista de Medicina, Universidade Federal de S\u00e3o Paulo, S\u00e3o Paulo, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durval C. B","family":"Santos","sequence":"additional","affiliation":[{"name":"Hospital Israelita Albert Einstein"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akemi","family":"Osawa","sequence":"additional","affiliation":[{"name":"Hospital Israelita Albert Einstein"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,9,21]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"622","DOI":"10.2967\/jnumed.115.161265","article-title":"68Ga-NOTA-UBI-29-41 as a PET tracer for detection of bacterial infection","volume":"57","year":"2016","journal-title":"J Nucl Med"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"108307","DOI":"10.1016\/j.nucmedbio.2022.11.001","article-title":"A decade of ubiquicidin development for PET imaging of infection: a systematic review","volume":"116-117","year":"2023","journal-title":"Nucl Med Biol"},{"key":"bib3-20250621","first-page":"819702","article-title":"Highlights of the latest developments in radiopharmaceuticals for infection imaging and future perspectives","volume":"9","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4103\/wjnm.WJNM_103_20","article-title":"Evaluation of 68Ga-DOTA-ubiquicidin (29\u201341) for imaging Staphylococcus aureus (staph A) infection and turpentine-induced inflammation in a preclinical setting","volume":"20","year":"2021","journal-title":"World J Nucl Med"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1097\/RLU.0000000000001464","article-title":"68Ga-DOTA ubiquicidin PET\/CT in an infected implant","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib6-20250621","first-page":"567","article-title":"Antimicrobial peptide 99mTc-ubiquicidin 29-41 as human infection-imaging agent: clinical trial","volume":"46","year":"2005","journal-title":"J Nucl Med"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"334","DOI":"10.2967\/jnumed.117.200048","article-title":"68Ga-NOTA-functionalized ubiquicidin: cytotoxicity, biodistribution, radiation dosimetry, and first-in-human PET\/CT imaging of infections","volume":"59","year":"2018","journal-title":"J Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004866","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:05:39Z","timestamp":1750532739000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,21]]},"references-count":7,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004866","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,21]]}}}